effectiveness of oral semaglutide 50 mg #semaglutide daily was associated with body weight reduction and improved cardiometabolic risk factors in East Asian adults with overweight or #obesity, with or without type 2 #diabetes. https://ja.ma/41sPiYj 🥼🧪Slide Deck: Efficacy and safety

What Clinical Trials Show In clinical trials of FDA-approved semaglutide (Wegovy) and tirzepatide (Zepbound): Semaglutide (Wegovy): In large clinical trials of FDA-approved products, average weight loss was meaningful over roughly 68 weeks when paired with lifestyle support (reduced-calorie diet and increased physical activity)

Became anemic

Discussion While there is mounting evidence for the mental health effects of GLP-1 agonists, these cases are the first, to our knowledge, to demonstrate a temporal correlation between administration of tirzepatide, a dual GLP-1/GIP agonist, and improvement in mental health symptoms

Mucinex D: Contains Pseudoephedrine